logo
episode-header-image
Oct 2023
2m 37s

Blood Test for Alzheimer Disease

AMERICAN ACADEMY OF NEUROLOGY
About this episode

Dr. Rae Bacharach discusses the Neurology Today article, "Individuals Can Now Request a Blood Test for Alzheimer disease - 
Why Some Dementia Experts Are Wary". 

Show references: https://journals.lww.com/neurotodayonline/fulltext/2023/10190/individuals_can_now_request_a_blood_test_for.2.aspx

Up next
Today
September 7, 2026 Capitol Hill Report: BrainPAC
In this episode, Dr. Jose Posas reviews the Capitol Hill Report from September 7th, discussing the busy month ahead for Congress, BrainPAC, and a couple of other advocacy news items. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get inv ... Show More
2m 16s
Yesterday
Comparison of the Efficacy and Safety of Myasthenia Gravis Treatments - Part 2
In part two of this series, Dr. Aaron Zelikovich and Dr. Bhaskar Roy discuss recommendations to help neurologists navigate the expanding landscape of myasthenia gravis treatments. Show citation: McLaren NP, Rosati M, Zhong W, et al. Comparison of the Efficacy and Safety of Myasth ... Show More
1m 52s
Sep 14
Bridging the Artificial Intelligence Training Gap - Part 2
In the second episode of this series, Dr. Justin Abbatemarco and Dr. Sara Marceglia discuss the risks of incorporating AI into clinical practice. Show citation: Vozzi C, Sibilla M, Sandri D, et al. Education Research: Bridging the Artificial Intelligence Training Gap: Evidence fr ... Show More
3m 9s
Recommended Episodes
May 2025
Diagnosis of Alzheimer Disease Using Plasma Biomarkers
Dr. Greg Cooper talks with Dr. Joseph Therriault about the use of plasma biomarkers in diagnosing Alzheimer disease, emphasizing the importance of interpreting these biomarkers within the clinical context of the patient. Read the related article in Nature. Disclosures can be foun ... Show More
21m 31s
Sep 2023
September 2023 Medical News Summary
tail spinning
11m 19s
Sep 2023
Should You Get a Blood Test For Alzheimer's?
Consumers can now get easy tests for Alzheimer’s. But these tests may not really help patients that much—yet. Learn more about your ad choices. Visit megaphone.fm/adchoices 
10m 31s
Jul 2024
COVID-19 cases, West Nile news, plus new Alzheimer's disease and colon cancer screening blood tests
How is Alzheimer's diagnosed? Is there a new blood test for colon cancer? Is West Nile virus deadly? Is West Nile virus curable? How bad is COVID right now? Our guest is American Medical Association Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. AM ... Show More
11m 32s
Jan 2022
Alzheimer Disease: Diffusion Tensor MRI and amyloid PET
Dr. Manisha Bahl interviews Dr. Jeffrey Prescott. Diffuse Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort. Prescott et al. Radiology 2022; 302:143–150.  
11m 41s
Dec 2023
Dementia vs Alzheimer's: Signs, symptoms and preventing Alzheimer's disease with Lisa McGuire, PhD
Following National Alzheimer’s Disease Awareness Month, the CDC shares what physicians and patients need to know about the disease. Lisa McGuire, PhD, lead epidemiologist at the CDC, discusses the importance of catching Alzheimer’s early, its risk factors and barriers to make Alz ... Show More
13m 18s
Aug 2023
Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease
<p>In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews considerations for their use in patients with Alzheimer disease.<br /> <br /> <stron ... Show More
28m 48s
Oct 2024
Newly FDA Approved Alzheimer’s Biomarkers Testing: How to Implement Such Tests in Core Laboratory?
<p>The diagnostic paradigm for Alzheimer&apos;s disease (AD) has rapidly shifted in the last five years as fluid-based biomarker testing has emerged as a reliable, accurate, and accessible means to detect amyloid pathology when evaluating a patient for cognitive decline. This pod ... Show More
35m 34s
Dec 2022
Beau Ances on amyloid biomarkers in Alzheimer’s
Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology. Read the full article: Comparison of amyloid burden ... Show More
12m 27s